{"organizations": [], "uuid": "a892e661f8beaefb3d292030b48cd12592b6bfac", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ascendis-pharma-reports-full-year/brief-ascendis-pharma-reports-full-year-2017-financial-results-idUSASC09U1M", "country": "US", "domain_rank": 408, "title": "BRIEF-Ascendis Pharma Reports Full Year 2017 Financial Results", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-28T23:06:00.000+03:00", "replies_count": 0, "uuid": "a892e661f8beaefb3d292030b48cd12592b6bfac"}, "author": "", "url": "https://www.reuters.com/article/brief-ascendis-pharma-reports-full-year/brief-ascendis-pharma-reports-full-year-2017-financial-results-idUSASC09U1M", "ord_in_thread": 0, "title": "BRIEF-Ascendis Pharma Reports Full Year 2017 Financial Results", "locations": [], "entities": {"persons": [{"name": "finan", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 28, 2018 / 8:07 PM / Updated 14 minutes ago BRIEF-Ascendis Pharma Reports Full Year 2017 Financial Results Reuters Staff \nMarch 28 (Reuters) - Ascendis Pharma A/S: \n* ASCENDIS PHARMA A/S REPORTS FULL YEAR 2017 FINANCIAL RESULTS \n* ASCENDIS PHARMA A/S - RARE DISEASE ENDOCRINOLOGY PIPELINE ADVANCES, WITH SIGNIFICANT MILESTONES ANTICIPATED OVER NEXT TWELVE MONTHS \n* ASCENDIS PHARMA A/S - AS OF DEC 31, 2017, HAD CASH AND CASH EQUIVALENTS OF EUR 195.4 MILLION COMPARED TO EUR 180.3 MILLION AS OF DEC 31, 2016 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-28T23:06:00.000+03:00", "crawled": "2018-03-28T23:26:48.014+03:00", "highlightTitle": ""}